Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

18.61
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
10.85
Today|||52-Week Range
38.31
-48.66%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Operating ActivitiesNet Income / Starting Line-982.8M661.3M-6.2B689.4M
 
 
 
 
 
Depreciation327.7M495.2M598.2M525.5M
 
 
 
 
 
Total Other Cash Flow2.1B26.8M6.5B591.6M
 
 
 
 
 
Funds From Operations1.5B959.4M993.5M1.2B
 
 
 
 
 
Funds From/For Other Operating Expenses46.7M474.5M225.7M62.1M
 
 
 
 
 
Net Cash Flow - Operating Activities1.4B484.8M767.8M1.1B
 
 
 
 
 
 
InvestingCapital Expenditures-331.5M-208.4M-200.2M-211.8M
 
 
 
 
 
Fixed Asset Disposal--1.5B79.4M150.2M
 
 
 
 
Net Assets From Acquisitions -114.8M0.000.000.00
 
 
Other Investing - Uses-376.8M-28.9M-281.4M-171.0M
 
 
 
 
 
Other Investing - Sources-1.8B0.000.00--
 
 
Net Cash Flow Investing-643.6M1.2B-402.2M-232.6M
 
 
 
 
 
 
FinancingShort Term Borrowings678.3M-1.4B-135.1M-138.1M
 
 
 
 
 
Long Term Borrowings-111.6M0.00538.9M-20.8M
 
 
 
 
Long Term Debt Reduction-951.8M0.00-603.0M-424.1M
 
 
 
 
Net Proceeds Stock Sale-2.1M0.000.000.00
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total-406.2M-424.0M-425.2M-182.0M
 
 
 
 
 
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing25.4M7.2M53.8M48.3M
 
 
 
 
 
Net Cash Flow - Financing-818.8M-1.8B-678.3M-813.2M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-496.8M28.9M1.1M6.8M
 
 
 
 
 
 
Net Change In Cash-49.9M-119.7M-312.7M80.8M